(Q50800599)

English

Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.

scientific article published on 5 February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

0 references

decision support system

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

Loek van Alphen

5

object named as

van Alphen L

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

author name string

Hubben GA

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

Bos JM

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

Glynn DM

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

van der Ende A

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

Postma MJ

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

language of work or name

0 references

publication date

5 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

25

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

18

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

3669-3678

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Pneumococcal meningitis in children: prognostic indicators and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Outcomes of bacterial meningitis in children: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Meningitis in infancy in England and Wales: follow up at age 5 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

New vaccines for the prevention of pneumococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

The burden of otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Cost Effectiveness of Pneumococcal Vaccination for Infants and Children with the Conjugate Vaccine PnC-7 in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Cost-effectiveness studies of pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Etiology and treatment of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Clinical features and prognostic factors in adults with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Clinical manifestations and course of meningococcal disease in 562 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Handling uncertainty in cost-effectiveness models

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Towards a healthier discount procedure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

A decision chart for assessing and improving the transferability of economic evaluation results between countries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.088

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.01.088

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/17360082

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50800599&oldid=1638078028"